Natural killer activity and its changes among participants in a smoking cessation intervention program - a prospective pilot study of 6 months' duration

Journal of Epidemiology

Volumn 11, Issue 5, 2001, Pages 238-242

  Ioka, Akiko ^a   Nakamura, Masakazu ^a   Shirokawa, Noriko ^a   Kinoshita, Tomoko ^a   Masui, Shizuko ^a   Imai, Kazue ^a   Nakachi, Kei ^a   Oshima, Akira ^a  

^a Osaka Cancer Prevention and Detection Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE;

AGED; ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NATURAL KILLER CELL; PILOT STUDY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SMOKING; SMOKING CESSATION; URINE;

AGED; COTININE; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SMOKING; SMOKING CESSATION;

EID: 37849185148     PISSN: 09175040     EISSN: None     Source Type: Journal    
DOI: 10.2188/jea.11.238     Document Type: Article

References (17)

1. Hirayama T. Life-style and mortality. A large-scale census-based cohort study in Japan. Contributions to Epidemiology and Biostatistics. Vol. 6. Karger. 1990; ISBN 3-8055-5201-7.
2. Tsukuma H, Tanaka H, Ajiki W, Oshima A, Yoshino K. Incidence of second primary cancers and their risk modifiers, with special regard to head and neck cancers. J Jpn Bronchoesophagol Soc, 1998; 49: 161-167. (in Japanese)
3. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR. Role of NK cells in tumour growth and metastasis in beige mice. Nature, 1980; 284:622-624.
4. Roder JC, Haliotis T, Klein M et al. A new immunodeficiency disorder in humans involving NK cells. Nature, 1980; 284:553-555.
5. Abo T, Roder JC, Abo W, Cooper MD, Balch CM. Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest, 1982; 70: 193-197.
6. Sullivan JL, Byron KS, Brewster FE, Purtilo DT. Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science, 1980; 210:543-555.
7. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet, 2000; 356: 1795-1799.
8. Nakachi K, Imai K. Environmental and physiological influences on human natural killer cell activity in relation to good health practices. Jpn J Cancer Res, 1992; 83:798-805.
9. Johnson JD, Houchens DP, Kluwe WM, Craig DK, Fisher GL. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol, 1990; 20: 369-395.
10. Kusaka Y, Kondo H, Morimoto K. Healthy lifestyle are associated with higher natural killer cell activity. Prev Med, 1992; 21:602-615.
11. Inoue C, Takeshita T, Kondo H, Morimoto K. Healthy lifestyle are associated with higher lymphokine-activated killer cell activity. Prev Med, 1996; 25: 717-724.
12. Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Med J Aust, 1983; 2: 425-429.
13. Meliska CJ, Stunkard ME, Gilbert DG, Jensen RA, Martinko JM. Immune function in cigarette smokers who quit smoking for 31 days. J Allergy Clin Immunol, 1995; 95:901-910.
14. U.S. Department of Health and Human Services. The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes. Report of the NCI Expert Committee. Smoking and Tobacco Control Monographs No. 7. National Institutes of Health; National Cancer Institute. NIH Publication 1996; No. 96-4028.
15. Evans DL, Leserman J, Pedersen CA et al. Immune correlates of stress and depression. Psychopharmacol Bull, 1989; 25: 319-324.
16. Kiecolt-Glaser JK, Glaser R, Strain EC et al. Modulation of cellular immunity in medical students. J Behav Med, 1986; 9:5-21.
17. Levy SM, Herberman RB, Simons A et al. Persistently low natural killer cell activity in normal adults: immunological, hormonal and mood correlates. Nat Immun Cell Growth Regul, 1989; 8: 173-186.